HeartsciencesHSCS
13F holders, Q2 2024 (June 30)7holders
$5.21avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding Heartsciences Inc. (HSCS) in their 13F filings. The largest holders were UBS Group AG ($33K), Morgan Stanley ($12K) and Tower Research Capital LLC (TRC) ($3K).
- Company
- Heartsciences Inc.
- Filed as
- HEART TEST LABORATORIES INC (Q2 2024)
- CUSIP
- 42254E302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $53K |
| Exits | 0 | $0 |
Ownership 7 holders
| UBS Group AG | 0.00% | New | 6,396 | $33K |
| Morgan Stanley | 0.00% | New | 2,290 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 576 | $3K |
| Cultivar Capital, Inc. | 0.00% | New | 500 | $3K |
| Oliver Lagore Vanvalin Investment Group | 0.00% | New | 485 | $3K |
| Bank of America Corp. | 0.00% | New | 4 | $21 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $5 |
"% of holder's portfolio" is HSCS's weight in each manager's 13F, not the share of Heartsciences Inc. the manager owns.